Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Sulthiame

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Apnimed Publishes Positive Phase 2 Results of OSA in Lancet
    Apnimed Publishes Positive Phase 2 Results of OSA in Lancet

    03 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/apnimed-announces-publication-in-the-lancet-of-positive-phase-2-results-demonstrating-sulthiames-efficacy-in-obstructive-sleep-apnea-302602583.html

    PR NEWSWIRE
    03 Nov 2025
    Share Share
    Apnimed Expands Oral Pharmacotherapy Portfolio with Sulthiame
    Apnimed Expands Oral Pharmacotherapy Portfolio with Sulthiame

    25 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/apnimed-expands-portfolio-of-oral-pharmacotherapies-for-sleep-and-breathing-diseases-through-acquisition-of-global-rights-to-patents-covering-sulthiame-a-differentiated-carbonic-anhydrase-inhibitor-302438325.html

    PR NEWSWIRE
    25 Apr 2025
    Share Share